Massive transfusion: An overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy

Transfusion and Apheresis Science

Volumn 47, Issue 2, 2012, Pages 235-243

  Seghatchian, Jerard ^a   Samama, Meyer Michel ^b  

^a International Consultancy in Blood Components Technology   (United Kingdom)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BIOLOGICAL RESPONSE MODIFIER; DEXTRAN; FIBRINOGEN; FRESH FROZEN PLASMA; HETASTARCH; MAGNESIUM; PLASMA SUBSTITUTE; POTASSIUM; RANTES; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TRANEXAMIC ACID; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD TRANSFUSION; CELL MEMBRANE PERMEABILITY; CRYOPRECIPITATE; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; HEMOSTASIS; HUMAN; MASSIVE TRANSFUSION; MORTALITY; OUTCOME ASSESSMENT; PLASMA; PRACTICE GUIDELINE; RISK ASSESSMENT; SURVIVAL RATE; THROMBOCYTE;

BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; HEMORRHAGE; HUMANS; PLATELET COUNT;

EID: 84865411790     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.06.001     Document Type: Article

References (41)

1. Lier H., et al. Intensive Care Med 2011, 37:572-582.
2. Spinella P.H., et al. Blood Rev 2009, 23:231-240.
3. Shakur H., et al. Lancet 2010, 376:23-32.
4. Spinella P.C., et al. J Crit Care Med 2007, 35:2576-2581.
5. Seghatchian J., et al. Transfus Apher Sci 2002, 26:139-143.
6. Krailadsiri P., et al. Transfusion 2006, 46:407-417.
7. Bessos H., et al. Transfus Apher Sci 2005, 30:227.
8. Seghatchian J., et al. Transfus Apher Sci 2011, 45:75-84.
9. Spinella P.C., et al. Crit Care 2009, 13:R151.
10. Koch C.G., et al. N Engl J Med 2008, 358:1229-1239.
11. Spinella PC et al Transfus. Apher. Sci. doi:10.1016/j.trasci.2012.01.002.
12. Strauss R.G., et al. Transfus 2002, 42(1):27-36.
13. Gould S., et al. Am J Crit Care 2007, 16(1):39-48.
14. Cardo L.J., et al. Transfus Apher Sci 2008, 38(2):141-144.
15. Blajchman M.A., et al. Br J Haematol 1994, 86(2):347-350.
16. Valeri R.C., et al. Transfusion 2001, 41:977-983.
17. Fernandez F., et al. Br J Haematol 1985, 59(1):139-148.
18. Hiroshi A., et al. Transfus Apher Sci 2011, 44:277-281.
19. Gyonogyossy M.I.C., et al. Transfus Apher Sci 2011, 44:283-295.
20. Picker S.M., et al. Transfus Apher Sci 2011, 44:305-319.
21. Seghatchian J., et al. Transfus Apher Sci 2003, 29:105-117.
22. Blajchman M.A., et al. Semin Hematol 2001, 38((4)Suppl. 11):20-26.
23. Samama C.M., et al. Can J Anaesth 2005, 52(1):30-37.
24. Holcomb J.B., et al. Ann Surg 2008, 248:447-458.
25. Sinha R., et al. Transfus Apher Sci 2011, 45:171-174.
26. Cotton B., et al. J Trauma 2008, 64:1177-1182.
27. Gunter O.I., et al. J Trauma 2008, 65:527-534.
28. Daniel J.R., et al. J Am Coll Sug 2009, 209(2):198-205.
29. Johansson P., et al. J Vox Sang 2009, 96:111-118.
30. Davenport R., et al. Trauma 2011, 70:90-96.
31. Borgman MA et al. Vox Sang 2011 [epub].
32. Pati S., et al. J Trauma-Injury Infect Crit care 2010, 69(1):S55-S63.
33. Barillari G., et al. Blood Transfus 2012, 10:87-94.
34. Marrietta M., et al. Transfus Apher Sci 2011, 45:287-290.
35. Lavee J., et al. J Thorac Cardiovasc Surg 1989, 97:204-212.
36. Schochi H., et al. Crit Care 2011, 15(2):R83.
37. Brohi K., et al. J Trauma 2008, 64:1211-1217.
38. Ho K.M., et al. Transfusion 2011, 51:1669-1675.
39. van de Watering L. Transfusion 2011, 51:1847-1854.
40. Myburgh J.A. N Engl J Med 2011, 364:2543-2544.
41. Valeri C.R., Veech R.L. Transfus Apher Sci 2012, 46:121-123.